沙利多胺通过PI3K/AKT通路抑制前列腺癌的增殖和迁移
Ru-Han Liu1,1, Teng-Fei Ma2,3,1, Qin Yang3,4
1Department of combine traditional Chinese and Western Medicine, Huanggang Central Hospital, Huanggang, Hubei, China.
Cancer biomarkers : section A of Disease markers
|August 7, 2023
概括
沙利德,一种来自传统中医药的化合物,有效地抑制前列腺癌 (PCa) 细胞的增殖和迁移. 它还通过向PI3K/AKT信号通路来促进亡.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 分子生物学分子生物学
背景情况:
- 前列腺癌 (PCa) 是男性普遍存在的恶性瘤,通常在晚期被诊断出来.
- 目前对晚期PCa的治疗方法有限,经常出现耐药性,瘤复发和转移.
- 对于有效的PCa治疗,迫切需要新的治疗药物.
研究的目的:
- 为了研究传统中国草药的关键成分沙利德胺对前列腺癌的抗癌作用.
- 阐明沙利德胺在PCa细胞中作用的分子机制.
主要方法:
- 人类PCa细胞系 (PC3和DU145) 用沙利德化物治疗.
- 用CCK-8,殖民地形成,Transwell和Scratch试验来评估细胞活力,增殖和迁移.
- 与增殖,亡,迁移和PI3K/AKT通路相关的基因和蛋白质表达被通过RT-PCR和西方抹杀分析,并使用AKT激动剂进行救援实验.
主要成果:
- 沙利德胺显著抑制了PCa细胞的增殖,殖民地形成和迁移.
- 沙利德化物治疗导致PCa细胞中亡的增强.
- 沙利化物抑制PI3K/AKT信号通路,这种效应被AKT激动剂 (740Y-P) 逆转.
结论:
- 沙利德化物对前列腺癌细胞表现出抗癌特性.
- 沙利德胺抑制PCa细胞的增殖和迁移,同时促进细胞亡.
- 沙利德胺的抗癌作用是通过抑制PI3K/AKT信号通路来实现的.
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
3.7K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.7K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
The JAK-STAT Signaling Pathway
9.0K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.0K
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K


